Control Bionics Ltd Ordinary Shares CBL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.07
- Day Range
- A$0.07–0.07
- 52-Week Range
- A$0.03–0.10
- Bid/Ask
- A$0.07 / A$0.07
- Shares Outstanding
- 543.09M
- Market Cap
- A$35.30M
- Volume/Avg
- 10,000 / 553,422
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.97
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Control Bionics Ltd is a neurotechnology company commercialising objective, non-invasive neural-signal technology in clinical environments, built to scale across multiple markets. Its neural-signal platform captures physiological signals, including the electrical activity generated by muscles, with medical-grade precision, converting them into measurable, decision-ready outcomes. Its products include NeuroNode, NeuroStrip, NeuroNode Trilogy Systems, NeuroNode Duo, EyeGaze Duo, and others. Geographically, it derives a majority of its revenue from North America, with a presence in Australia, Japan, and other markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.controlbionics.com
Valuation
|
Metric
|
CBL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.24 |
Price/Sales | 4.97 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CBL
|
|---|---|
Quick Ratio | 1.26 |
Current Ratio | 1.54 |
Interest Coverage | −84.56 |
Quick Ratio
CBL
Profitability
|
Metric
|
CBL
|
|---|---|
Return on Assets (Normalized) | −77.44% |
Return on Equity (Normalized) | −107.80% |
Return on Invested Capital (Normalized) | −99.98% |
Return on Assets
CBL
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|L@@BR% | LOCK|Sf!>s | $176B | |||
| Medtronic PLC
MDT
| LOCK|ClNdlC | LOCK|y?%tH | $118B | |||
| Stryker Corp
SYK
| LOCK|JjDBCzW | LOCK|!r | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|hs^!^D | LOCK|!NDG | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Hm!<Z^?D | LOCK|z@<! | $50B | |||
| DexCom Inc
DXCM
| LOCK|&wP@W&P< | LOCK|<hfn | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<g^D>L> | LOCK|Fn | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|sn | LOCK|xb! | $24B | |||
| Steris PLC
STE
| LOCK|x^Kr#?V | LOCK|sp$T | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|nQCQ?LB | LOCK|@! | $18B |
United States